POST-COVID-19 PULMONARY SEQUELAE: PATHOPHYSIOLOGY, CLINICAL CHARACTERISTICS, RADIOLOGICAL FEATURES AND PULMONARY FUNCTION

Pham Minh Thu Vo1,, Chi Thien Dinh1, Xuan Quynh Tran1, Viet Hung Phan1, Thi Hong Tran Nguyen1, Thi Thanh Van Duong1, Trong Anh Tuan Tran2, Ngoc Thanh Long Nguyen2, Thi Thanh Tra Do2, Quoc Trung Trat2
1 Can Tho University of Medicine and Pharmacy
2 Can Tho University of Medicine and Pharmacy Hospital

Main Article Content

Abstract

COVID-19 has been known as a disease that makes significant influences on respiratory system with a wide range of severity. Lung damages after COVID-19 infection could be reversible or abnormally regenerative. This progression could lead to pulmonary fibrosis that causes dysfunction of ventilation-gas exchange and presents with prolonged dyspnea. Lung injuries and their recovery could be assessed by chest computed tomography imaging during follow-up of post-COVID-19 patients. The gradual accumulation of damages in the lung structure during acute period definitely has a serious impact on the respiratory capacity whose recovery has not been known. Spirometry and DLCO are the first-line pulmonary fuction tests to help assess the consequences of lung injuries leading to physiological dysfunction of the lungs.

Article Details

References

1. Amaya Jimeno-Almazán, Jesús G. Pallarés (2021), Post-COVID-19 Syndrome and the Potential Benefits of Exercise, Int. J. Environ. Res. Public Health, 18, 5329.
2. Cenko E., Badimon L., Bugiardini R. et al (2021), Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA), Cardiovascular Research, 117(14), pp.2705-2729.
3. Elham Atabati (2020), Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: A narrative review, Can J Respir Ther, 56, pp. 70-78.
4. Guler S.A., Ebner L., Beigelman C. et al (2021), Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study, Eur Respir J.
5. Han X., Fan Y., Alwalid O. et al (2021), Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia, Radiology, 299(1), pp. 177-186.
6. Harry Crook, Sanara Raza (2021), Long covid—mechanisms, risk factors, and management, BMJ.
7. Joshua J. Solomon, Brooke Heyman (2021), CT of Post-Acute Lung Complications of COVID-19, Radiology, 301, pp. 383-395.
8. Long Q., Li J., Hu X. et al (2021), Follow-Ups on Persistent Symptoms and Pulmonary
Function Among Post-Acute COVID-19 Patients: A Systematic Review and MetaAnalysis, Front. Med.
9. Raveendran A.V., Jayadevan R., Sashidharan S. (2021), “ Long COVID-19: An overview”, Diabetes & Metabolic syndrome: Clinical research & reviews, 15, pp. 869-875.
10. Suh Y.J., Hong H., Ohana M. et al (2021), Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis, Radiology, 298(2), pp. 70-80.
11. Torres-Castro R., Vasconcello-Castillo L. et al (2021), Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis, Pulmonology, 27, pp. 328-337.
12. Thomas Sonnweber, Sabina Sahanic (2021), Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial, Eur Respir J, 57.
13. Vinod Nikhra (2021), Respiratory Manifestations in COVID-19 and ‘Long Covid’: The Morbidity, Complications and Sequelae, Biomed J Sci & Tech Res, 36(3).
14. Writing Committee for the COMEBAC Study Group; Morin L, Savale L, et al (2021), Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19, JAMA, 325(15), pp. 1525-1534.
15. Wynn T.A. (2011), Integrating mechanisms of pulmonary fibrosis, J Exp Med, 208(7), pp. 1339-1350.